Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Bifidobacteria: Their Significance in Human Intestinal Health

Ishibashi, N., and Yaeshima, T., and Hayasawa, H., (1997) Bifidobacteria: Their Significance in Human Intestinal Health. Malaysian Journal of Nutrition, 3 (2). pp. 149-159. ISSN 1394-035X

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
919Kb

Official URL: http://nutriweb.org.my/publications/mjn003_2/mjn3n2_art6.pdf

Affiliations

Morinaga Milk Industry Co. Ltd., Kanagawa, Japan

Abstract

(no abstract provided in the article)

Item Type:Journal
Additional Information:This note was added by the search_and_modify.pl script.
Keywords:Bifidobacteria, Human Intestines, Faecal Characteristics
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:2634

1. Akiyama K, Hosono S, Takahashi E, Ishizeki S, Takigawa I, Imura S, Yamauchi K, Yaeshima T, Hayasawa H & Shimimura S. (1994). Effects of oral administration of Bifidobacterium breve on development of intestinal microflora in extremely premature infants. Acta Neonatological Japonica 30, 130-137.

2. Akiyama K, Shimada M, Ishizeki S, Takigawa I, Imura S, Yamauchi K, Hatano M, Abe N, Yaeshima T, Hayasawa H & Shimimura S. (1994). Effects of administration of Bifidobacterium in extremely premature infants: Development of intestinal microflora by orally administered Bifidobacterium longum (in comparison with Bifidobacterium breve). Acta Neonatologica Japonica. 30, 257-263.

3. Araya-Kojima T, Yaeshima T, Ishibashi N, Shimamura S and Hayasawa H. (1995). Inhibitory effects of Bifidobacterium longum BB536 on harmful intestinal bacteria. Bifidobacteria and Microflora. 14(2), 59-66.

4. Challa A, Rao DR, Chawan CB & Shackelford L. (1997). Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis. 18, 517-521.

5. Igarashi M, Iiyama Y, Kato R, Tomita M, Asami N & Ezawa I. (1994). Effect of Bifidobacterium longum and lactulose on the strength of bone in ovariectomized osteo-porosis model rat. Bifidus (Japan) 7, 139-147.

6. Ishibashi N & Shimamura S. (1993). Bifidobacteria: research and development in Japan. Fd. Tech. June 126-135.

7. Kulkarni N & Reddy BS. (1994). Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial -glucuronidase. Proc Soc Expt Biol Med. 207, 278-283.

8. Mayer JB. (1948). Lactic acid-bifidus milk. Zeitshrift f_r Kinderheilkunde, 65, 319-345.

9. Meile L, Ludwig W, Rueger U, Gut C, Kaufmann P, Dasen G, Wenger S & Teuber M. (1997). Bifidobacterium lactis sp. Nov., a moderately oxygen tolerant species isolated from fermented milk. Sys Appl Micro. 20, 57-64.

10. Mitsuoka T. (1978). Intestinal Bacteria and Health. Harcourt Brace Javanovich Japan Inc. Tokyo

11. Mitsuoka T. (1984). Taxonomy and ecology of bifidobacteria. Bifidobacteria and Microflora, 3(1) 11-28.

12. Mizota T, Tamura Y, Tomita M & Okonogi S. (1986). Lactulose as a sugar with physiological significance. Bulletin of the IDF. 212, 69-76.

13. Petury F. (1957). Bifidusflora bei Fraschenkindern durch bifidogene Substanzen (Bifidusfaktor). Zeitshrift f_r Kinderheilkunde. 79, 174-179.

14. Rasic JLJ & Kurmann JA. (1983) Effect of substrate on the growth of bifidobacteria. In: Bifidobacteria and their role. page 42-50, Birkha_ser.

15. Reddy BS & Rivenson A. (1993). Inhibitory effect of Bifidobacterium longum on colon, mammary and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f] quinoline, a food mutagen. Cancer Research 53, 3914-3918.

16. Sekine K, Toida T, Saito M, Kuboyama M, Kawashima T & Hashimoto Y. (1985). A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Research 45, 1300-1307.

17. Tamime AY, Marshall VME & Robinson RK. (1995). Microbiological and technological aspects of milks fermented by bifidobacteria. J of Dairy Res. 62, 151-187.

18. Tamura Y, Mizota T, Shimamura S & Tomita M. (1993). Lactulose and its application to the food and pharmaceutical industries. Bulletin of the IDF. 289, 43-53.

19. Terada A, Hara H, Kataoka M, & Mitsuoka T. (1992). Effect of lactulose on the composition and metabolic activity of the human faecal flora. Microbl Eco in Hlth and Dis. 5, 43-50.

20. Yaeshima T, Takahashi S, Ishibashi N & Shimamura S. (1996). Identification of bifidobacteria from dairy products and evaluation of a microplate hybridization method. Internat J of Fd Micro. 30, 303-313.

21. Yaeshima T, Takahashi S, Matsumoto N, Ishibashi N, Hayasawa H & Iino H. (1997). Effect of yogurt containing B. longum BB536 yogurt on the intestinal environment, fecal characteristics and defecation frequency. Bioscience and Microflora. 16, 73-77.

22. Yamazaki S, Tsuyuki S, Akashiba H, Kamimura H, Kimura M, Kawashima T & Ueda K. (1991). Immune response of Bifidobacterium-monoassociated mice. Bifidobacteria and Microflora 10, 19-31.

23. Yoshioka H, Fujita K, Sakata H, Murono K & Iseki K. (1991). Development of the normal intestinal flora and its clinical significance in infants and children. Bifidobacteria and Microflora 10(1) 11-17.

Repository Staff Only: item control page